{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:03:50Z","timestamp":1773968630665,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["ID22I10252"],"award-info":[{"award-number":["ID22I10252"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["ICN2021_045"],"award-info":[{"award-number":["ICN2021_045"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1231905"],"award-info":[{"award-number":["1231905"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1231851"],"award-info":[{"award-number":["1231851"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1231866"],"award-info":[{"award-number":["1231866"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1190830"],"award-info":[{"award-number":["1190830"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["12318866"],"award-info":[{"award-number":["12318866"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1240971"],"award-info":[{"award-number":["1240971"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["11221280"],"award-info":[{"award-number":["11221280"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["3240624"],"award-info":[{"award-number":["3240624"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["21251811"],"award-info":[{"award-number":["21251811"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["21210662"],"award-info":[{"award-number":["21210662"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["21221163"],"award-info":[{"award-number":["21221163"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["21242058"],"award-info":[{"award-number":["21242058"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["21230429"],"award-info":[{"award-number":["21230429"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014171","name":"Biomedical Research Consortium-Chile","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013907","name":"COPEC-UC Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013928","name":"Instituto Milenio en Inmunolog\u00eda e Inmunoterapia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ebiom.2025.106104","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T10:19:33Z","timestamp":1767349173000},"page":"106104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody"],"prefix":"10.1016","volume":"123","author":[{"given":"M\u00f3nica A.","family":"Far\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina A.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.","family":"Loaiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linmar","family":"Rodr\u00edguez-Guilarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0063-5896","authenticated-orcid":false,"given":"Jos\u00e9 T.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Pereira-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Mu\u00f1oz-Durango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena S.","family":"Pizarro-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn","family":"Diethelm-Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Pereira-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0788-3802","authenticated-orcid":false,"given":"Robinson A.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Bohmwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-5263","authenticated-orcid":false,"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10098","key":"10.1016\/j.ebiom.2025.106104_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106104_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/thoraxjnl-2018-212212","article-title":"Respiratory syncytial virus (RSV): a scourge from infancy to old age","volume":"74","author":"Coultas","year":"2019","journal-title":"Thorax"},{"issue":"22","key":"10.1016\/j.ebiom.2025.106104_bib3","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1073\/pnas.1217508110","article-title":"Impaired learning resulting from respiratory syncytial virus infection","volume":"110","author":"Espinoza","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.106104_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2015.05.003","article-title":"Inflammatory damage on respiratory and nervous systems due to hRSV infection","volume":"36","author":"Bohmwald","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ebiom.2025.106104_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2020.09.021","article-title":"Lung pathology due to hRSV infection impairs blood-brain barrier permeability enabling astrocyte infection and a long-lasting inflammation in the CNS","volume":"91","author":"Bohmwald","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79140-1","article-title":"Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy","volume":"10","author":"Pe\u00f1a","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106104_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/14787210.2024.2403147","article-title":"Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection","volume":"22","author":"Loaiza","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1 Pt A","key":"10.1016\/j.ebiom.2025.106104_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.imlet.2014.09.006","article-title":"Respiratory syncytial virus: pathology, therapeutic drugs and prophylaxis","volume":"162","author":"Gomez","year":"2014","journal-title":"Immunol Lett"},{"issue":"18","key":"10.1016\/j.ebiom.2025.106104_bib9","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1080\/14656566.2020.1806821","article-title":"Pharmacological management of human respiratory syncytial virus infection","volume":"21","author":"Kalergis","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"3 Pt 2","key":"10.1016\/j.ebiom.2025.106104_bib10","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1164\/ajrccm.163.supplement_1.2011112","article-title":"Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes","volume":"163","author":"Simoes","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106104_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/d41573-023-00085-x","article-title":"RSV vaccines score landmark FDA approvals","volume":"22","author":"Kingwell","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106104_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00195-7","article-title":"First RSV vaccine approvals","volume":"4","author":"Venkatesan","year":"2023","journal-title":"Lancet Microbe"},{"issue":"1707","key":"10.1016\/j.ebiom.2025.106104_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.58347\/tml.2024.1707a","article-title":"Editors from the medical letter in brief: RSV vaccine (Arexvy) for ages 50-59","volume":"66","year":"2024","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.ebiom.2025.106104_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105783","article-title":"A molecular perspective for the development of antibodies against the human respiratory syncytial virus","volume":"222","author":"Loaiza","year":"2024","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106104_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00006454-199802000-00006","article-title":"Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 study group","volume":"17","author":"Subramanian","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106104_bib16","article-title":"Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children","volume":"7","author":"Garegnani","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"388","key":"10.1016\/j.ebiom.2025.106104_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj1928","article-title":"A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants","volume":"9","author":"Zhu","year":"2017","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106104_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib19","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/s41467-019-12137-1","article-title":"A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein","volume":"10","author":"Tang","year":"2019","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.ebiom.2025.106104_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01205-21","article-title":"Mechanism of cross-resistance to fusion inhibitors conferred by the K394R mutation in respiratory syncytial virus fusion protein","volume":"95","author":"Tang","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.106104_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2014.02.010","article-title":"Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein","volume":"454\u2013455","author":"Bates","year":"2014","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106104_bib22","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1128\/AAC.00842-16","article-title":"Trivalency of a nanobody specific for the human respiratory syncytial virus fusion glycoprotein drastically enhances virus neutralization and impacts escape mutant selection","volume":"60","author":"Palomo","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib23","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/s41598-018-22826-4","article-title":"Genetic variations in the fusion protein of respiratory syncytial virus isolated from children hospitalized with community-acquired pneumonia in China","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40760-y","article-title":"Genome-wide study of globally distributed respiratory syncytial virus (RSV) strains implicates diversification utilizing phylodynamics and mutational analysis","volume":"13","author":"Shishir","year":"2023","journal-title":"Sci Rep"},{"issue":"31","key":"10.1016\/j.ebiom.2025.106104_bib25","doi-asserted-by":"crossref","first-page":"E3214","DOI":"10.1073\/pnas.1400760111","article-title":"Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells","volume":"111","author":"C\u00e9spedes","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.ebiom.2025.106104_bib26","doi-asserted-by":"crossref","first-page":"10508","DOI":"10.1128\/JVI.74.22.10508-10513.2000","article-title":"Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection","volume":"74","author":"Hallak","year":"2000","journal-title":"J Virol"},{"issue":"52","key":"10.1016\/j.ebiom.2025.106104_bib27","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106104_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hyb.1994.13.303","article-title":"Development of anti-human B blood group monoclonal antibodies suitable as a blood typing reagent","volume":"13","author":"Becker","year":"1994","journal-title":"Hybridoma"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106104_bib29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41385-019-0171-3","article-title":"Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease","volume":"12","author":"Malinczak","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ebiom.2025.106104_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-8904-1_5","article-title":"High-Throughput, biosensor-based approach to examine bone morphogenetic protein (BMP)-Receptor interactions","volume":"1891","author":"Aykul","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ebiom.2025.106104_bib31","series-title":"Screening of protein candidates","author":"Zhang","year":"2016"},{"key":"10.1016\/j.ebiom.2025.106104_bib32","series-title":"Immobilization method","author":"Inagawa","year":"2004"},{"key":"10.1016\/j.ebiom.2025.106104_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.868448","article-title":"Exploring sex-related differences in microglia may be a game-changer in precision medicine","volume":"14","author":"Lynch","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"20","key":"10.1016\/j.ebiom.2025.106104_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cells13201724","article-title":"Sex differences in astrocyte activity","volume":"13","author":"Gozlan","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2025.106104_bib35","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J Vis Exp"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106104_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ph14040340","article-title":"Contribution of pro-inflammatory molecules induced by respiratory virus infections to neurological disorders","volume":"14","author":"Bohmwald","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nprot.2006.20","article-title":"Digging and marble burying in mice: simple methods for in vivo identification of biological impacts","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2025.106104_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1283120","article-title":"Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection","volume":"14","author":"Brady","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106104_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jmv.23807","article-title":"Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies","volume":"86","author":"G\u00f3mez","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2025.106104_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109839","article-title":"TJ-M2010-5, a self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-kappaB pathway","volume":"354","author":"Xie","year":"2022","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ebiom.2025.106104_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pbb.2018.04.005","article-title":"JSH-23 prevents depressive-like behaviors in mice subjected to chronic mild stress: effects on inflammation and antioxidant defense in the hippocampus","volume":"169","author":"Wang","year":"2018","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106104_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081753","article-title":"New insights contributing to the development of effective vaccines and therapies to reduce the pathology caused by hRSV","volume":"18","author":"G\u00e1lvez","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106104_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106104_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/CVI.00609-15","article-title":"Brief history and characterization of enhanced respiratory syncytial virus disease","volume":"23","author":"Acosta","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ebiom.2025.106104_bib45","article-title":"Post-licensure safety of respiratory syncytial virus vaccines, vaccine adverse event reporting system, United States, May 2023-December 2024","volume":"56","author":"Li","year":"2025","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.ebiom.2025.106104_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1624007","article-title":"Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia","volume":"16","author":"Alandijany","year":"2025","journal-title":"Front Immunol"},{"issue":"32","key":"10.1016\/j.ebiom.2025.106104_bib47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7332e1","article-title":"Use of respiratory syncytial virus vaccines in adults aged >\/=60 years: updated Recommendations of the advisory committee on immunization practices - United States, 2024","volume":"73","author":"Britton","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106104_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0023","article-title":"Monoclonal antibody for the prevention of respiratory syncytial virus in infants and children: a systematic review and network meta-analysis","volume":"6","author":"Sun","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106104_bib49","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/INF.0000000000001916","article-title":"Safety, tolerability and pharmacokinetics of MEDI8897, an extended half-life single-dose respiratory syncytial virus prefusion F-targeting monoclonal antibody administered as a single dose to healthy preterm infants","volume":"37","author":"Domachowske","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"16","key":"10.1016\/j.ebiom.2025.106104_bib50","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1128\/JVI.02699-09","article-title":"Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion","volume":"84","author":"Huang","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.106104_bib51","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2147\/IDR.S379660","article-title":"New developments and challenges in antibody-based therapies for the respiratory syncytial virus","volume":"16","author":"Diethelm-Varela","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106104_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01714-16","article-title":"Safety, tolerability, and pharmacokinetics of MEDI8897, the respiratory syncytial virus prefusion F-targeting monoclonal antibody with an extended half-life, in healthy adults","volume":"61","author":"Griffin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2516948","article-title":"Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: safety and tolerability in healthy Chinese participants","volume":"21","author":"He","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106104_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106104_bib55","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1093\/infdis\/jiae581","article-title":"A phase 1b\/2a trial of a half-life extended respiratory syncytial virus neutralizing antibody, Clesrovimab, in healthy preterm and full-term infants","volume":"231","author":"Madhi","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2025.106104_bib56","article-title":"Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial","volume":"39","author":"Mori","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"34","key":"10.1016\/j.ebiom.2025.106104_bib57","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices - United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106104_bib58","article-title":"New Anti-RSV nucleoprotein monoclonal antibody pairs discovered using rabbit phage display technology","volume":"12","author":"Baurand","year":"2023","journal-title":"Antibodies (Basel)"},{"issue":"39","key":"10.1016\/j.ebiom.2025.106104_bib59","doi-asserted-by":"crossref","first-page":"14999","DOI":"10.1073\/pnas.0802555105","article-title":"Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells","volume":"105","author":"Gonz\u00e1lez","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/imm.12541","article-title":"Contribution of Fcgamma receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells","volume":"147","author":"G\u00f3mez","year":"2016","journal-title":"Immunology"},{"issue":"Pt 8","key":"10.1016\/j.ebiom.2025.106104_bib61","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1099\/vir.0.053025-0","article-title":"The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid","volume":"94","author":"Bakker","year":"2013","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41392-023-01602-5","article-title":"Cryo-EM structure of the nucleocapsid-like assembly of respiratory syncytial virus","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106104_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102337","article-title":"Importance of RNA length for in vitro encapsidation by the nucleoprotein of human respiratory syncytial virus","volume":"298","author":"Gonnin","year":"2022","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106104_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the \u2018high-hanging fruit\u2019","volume":"17","author":"Carter","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106104_bib65","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.inf.0000133165.85909.08","article-title":"Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection","volume":"23","author":"S\u00e1ez-Llorens","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106104_bib66","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/cts.13290","article-title":"A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults","volume":"15","author":"Orito","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106104_bib67","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s12276-022-00870-5","article-title":"An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies","volume":"54","author":"Ko","year":"2022","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106104_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103746","article-title":"Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life","volume":"25","author":"Grevys","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106104_bib69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/19420862.2017.1389355","article-title":"Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics","volume":"10","author":"Piche-Nicholas","year":"2018","journal-title":"MAbs"},{"issue":"8\u20139","key":"10.1016\/j.ebiom.2025.106104_bib70","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.molimm.2009.02.002","article-title":"Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors","volume":"46","author":"Bertolotti-Ciarlet","year":"2009","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106104_bib71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jps.24136","article-title":"Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidation","volume":"104","author":"Gao","year":"2015","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106104_bib72","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jps.24444","article-title":"Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins","volume":"104","author":"Liu","year":"2015","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106104_bib73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/mabs.20737","article-title":"Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans","volume":"4","author":"Yu","year":"2012","journal-title":"MAbs"},{"issue":"16","key":"10.1016\/j.ebiom.2025.106104_bib74","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1073\/pnas.1402458111","article-title":"Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy","volume":"111","author":"Hiatt","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.106104_bib75","first-page":"347","article-title":"The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection","volume":"372","author":"Boukhvalova","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ebiom.2025.106104_bib76","series-title":"Specific monoclonal antibody against the N antigen OF human respiratory syncytial virus (HRSV) useful for treating infection, detection thereof and diagnosis","author":"Kalergis Parra","year":"2020"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:18:44Z","timestamp":1773962324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":76,"alternative-id":["S2352396425005547"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106104","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106104"}}